2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature since 2005 and the discussion and agreement among 21 international experts, 2 patients and 2 physiot...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of the rheumatic diseases Vol. 70; no. 6; p. 896
Main Authors:	Braun, J, van den Berg, R, Baraliakos, X, Boehm, H, Burgos-Vargas, R, Collantes-Estevez, E, Dagfinrud, H, Dijkmans, B, Dougados, M, Emery, P, Geher, P, Hammoudeh, M, Inman, R D, Jongkees, M, Khan, M A, Kiltz, U, Kvien, Tk, Leirisalo-Repo, M, Maksymowych, W P, Olivieri, I, Pavelka, K, Sieper, J, Stanislawska-Biernat, E, Wendling, D, Ozgocmen, S, van Drogen, C, van Royen, Bj, van der Heijde, D
Format:	Journal Article
Language:	English
Published:	England 01-06-2011
Subjects:	Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antirheumatic Agents - therapeutic use Humans International Cooperation Practice Guidelines as Topic Spondylitis, Ankylosing - drug therapy Spondylitis, Ankylosing - therapy Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature since 2005 and the discussion and agreement among 21 international experts, 2 patients and 2 physiotherapists in a meeting in February 2010. Each original bullet point was discussed in detail and reworded if necessary. Decisions on new recommendations were made - if necessary after voting. The strength of the recommendations (SOR) was scored on an 11-point numerical rating scale after the meeting by email. These recommendations apply to patients of all ages that fulfill the modified NY criteria for AS, independent of extra-articular manifestations, and they take into account all drug and non-drug interventions related to AS. Four overarching principles were introduced, implying that one bullet has been moved to this section. There are now 11 bullet points including 2 new ones, one related to extra-articular manifestations and one to changes in the disease course. With a mean score of 9.1 (range 8-10) the SOR was generally very good.
ISSN:	1468-2060
DOI:	10.1136/ard.2011.151027